Emergency Neurological Life Support: Pharmacotherapy

被引：16
作者：
Brophy, Gretchen M. [1 ,2 ]
Human, Theresa [3 ]
Shutter, Lori [4 ]
机构：
[1] Virginia Commonwealth Univ, Dept Pharmacotherapy & Outcomes Sci, Richmond, VA 23284 USA
[2] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA
[3] Washington Univ, Barnes Jewish Hosp, Dept Clin Pharm, St Louis, MO USA
[4] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Dept Neurol & Neurosurg, Pittsburgh, PA USA
来源：
NEUROCRITICAL CARE | 2015年 / 23卷
关键词：
ENLS; Pharmacotherapy; Medication; Adverse drug event; Drug interaction; PROTHROMBIN COMPLEX CONCENTRATE; HEALTH-CARE PROFESSIONALS; ACTIVATED FACTOR-VII; HYPERTONIC SALINE; EXCESSIVE ANTICOAGULATION; ANTIFIBRINOLYTIC THERAPY; REVERSAL; GUIDELINES; MANAGEMENT; MANNITOL;
D O I：
10.1007/s12028-015-0158-1
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
The appropriate use of medications during Emergency Neurological Life Support (ENLS) is essential to optimize patient care. Important considerations when choosing the appropriate agent include the patient's organ function and medication allergies, potential adverse drug effects, drug interactions, and critical illness and aging pathophysiologic changes. Critical medications used during ENLS include hyperosmolar therapy, anticonvulsants, antithrombotics, anticoagulant reversal and hemostatic agents, anti- shivering agents, neuromuscular blockers, antihypertensive agents, sedatives, vasopressors and inotropes, and antimicrobials. This article focuses on the important pharmacokinetic and pharmacodynamics characteristics, advantages and disadvantages, and clinical pearls of these therapies, providing practitioners with essential drug information to optimize pharmacotherapy in acutely ill neurocritical care patients.
引用
收藏
页码：S48 / S68
页数：21
相关论文
共 55 条
[31]   Magnesium as an adjuvant to postoperative analgesia:: A systematic review of randomized trials [J].
Lysakowski, Christopher ;
Dumont, Lionel ;
Czarnetzki, Christoph ;
Tramer, Martin R. .
ANESTHESIA AND ANALGESIA, 2007, 104 (06) :1532-1539
[32]   Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage [J].
Mayer, Stephan A. ;
Brun, Nikolai C. ;
Begtrup, Kamilla ;
Broderick, Joseph ;
Davis, Stephen ;
Diringer, Michael N. ;
Skolnick, Brett E. ;
Steiner, Thorsten .
NEW ENGLAND JOURNAL OF MEDICINE, 2008, 358 (20) :2127-2137
[33]   Buspirone and meperidine synergistically reduce the shivering threshold [J].
Mokhtarani, M ;
Mahgoub, AN ;
Morioka, N ;
Doufas, AG ;
Dae, M ;
Shaughnessy, TE ;
Bjorksten, AR ;
Sessler, DL .
ANESTHESIA AND ANALGESIA, 2001, 93 (05) :1233-1239
[34]   Low-Molecular-Weight Heparin Overdose: Management by Observation [J].
Monte, Andrew A. ;
Bodmer, Michael ;
Schaeffer, Tammi H. .
ANNALS OF PHARMACOTHERAPY, 2010, 44 (11) :1836-1839
[35]   Guidelines for the Management of Spontaneous Intracerebral Hemorrhage A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [J].
Morgenstern, Lewis B. ;
Hemphill, J. Claude, III ;
Anderson, Craig ;
Becker, Kyra ;
Broderick, Joseph P. ;
Connolly, E. Sander, Jr. ;
Greenberg, Steven M. ;
Huang, James N. ;
Macdonald, R. Loch ;
Messe, Steven R. ;
Mitchell, Pamela H. ;
Selim, Magdy ;
Tamargo, Rafael J. .
STROKE, 2010, 41 (09) :2108-2129
[36]  
Mullner M., 2004, Cochrane Database Syst Rev, DOI DOI 10.1002/14651858.CD003709
[37]   Intravenous versus subcutaneous vitamin K1 in reversing excessive oral anticoagulation [J].
Nee, R ;
Doppenschmidt, D ;
Donovan, DJ ;
Andrews, TC .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 83 (02) :286-+
[38]  
Palma L, 2006, J Neurosurg Sci, V50, P63
[39]   Pharmacologic Management of Brain Edema [J].
Papangelou, Alexander ;
Lewin, John J., III ;
Mirski, Marek A. ;
Stevens, Robert D. .
CURRENT TREATMENT OPTIONS IN NEUROLOGY, 2009, 11 (01) :64-73
[40]   Acute renal failure following massive mannitol infusion [J].
Pérez-Pérez, AJ ;
Pazos, B ;
Sobrado, J ;
Gonzalez, L ;
Gándara, A .
AMERICAN JOURNAL OF NEPHROLOGY, 2002, 22 (5-6) :573-575
123456